Chamber-like Cardiac Organoids: A New Window into Human Heart Development and Cardiotoxicity
A new study in Nature Communications introduces self-assembled chamber-like cardiac organoids (CCOs) derived from human pluripotent stem cells that recapitulate key aspects of early human heart chamber formation. Unlike previous cardiac organoid systems, these CCOs develop a stable lumen surrounded by an outer myocardial layer and an inner endocardial-like endothelial layer, remain structurally intact for more than 90 days, and provide a visually accessible platform for developmental biology and drug safety testing.
Key findings:
🫀 Self-organized cardiac chambers
CCOs reproducibly formed a single chamber with >95% success.
Architecture closely mimicked embryonic heart organization, including TNNT2⁺ myocardium and CDH5⁺ endocardial-like lining.
Organoids exhibited spontaneous contractions (~60 BPM) and coordinated calcium transients.
🧬 Developmental regulators uncovered
Chamber morphogenesis required coordinated FGF, WNT, BMP, Activin A, and Retinoic Acid signaling.
Genetic knockout studies identified HAND1, NR2F2, TFAP2B, and ETS1 as critical regulators.
Loss of NR2F2 or TFAP2B impaired chamber formation, while ETS1 deficiency abolished organized chamber development.
🔬 Endocardium–myocardium communication
Single-cell RNA-seq revealed extensive endothelial–cardiomyocyte crosstalk through WNT, BMP, NOTCH, VEGF, EPHA, and NRG signaling.
Endothelial cells resembled fetal endocardial populations, supporting developmental relevance.
💊 Cardiotoxicity screening platform
Isoproterenol increased beating frequency without structural damage.
Doxorubicin and daunorubicin induced chamber collapse, reduced viability, elevated LDH release, and activated stress/inflammatory markers (ANP, TNFA, IL6).
Structural changes were directly visible under brightfield microscopy, enabling rapid phenotypic screening.
⚠️ Teratogenicity assessment
Thalidomide and acitretin severely disrupted chamber development and contractility.
The model distinguished developmental-stage-specific toxicity effects, highlighting utility for embryotoxicity testing.
Why this matters
Current cardiac organoids often lack durable chamber architecture and clear endocardial–myocardial organization. This study establishes a robust platform that links developmental signaling, tissue self-organization, and functional readouts in a single system. Beyond modeling congenital heart development, these chambered organoids may accelerate cardiotoxicity prediction, teratogenicity screening, disease modeling, and regenerative medicine research.
Reference
Zou X, Wang F, Zheng H, et al. Self-assembled chamber-like cardiac organoids for modeling cardiac chamber formation and cardiotoxicity assessment. Nature Communications (2026). DOI: 10.1038/s41467-026-73822-6.
#CardiacOrganoids #StemCells #HeartDevelopment #Cardiotoxicity #SingleCellGenomics #RegenerativeMedicine #DrugDiscovery #NatureCommunications #Organoids #DevelopmentalBiology